Long‐Term Outcomes in Patients With Trisomy 21 and Obstructive Sleep Apnea
Otolaryngology–Head and Neck Surgery · 2024-02 · 170 (2) · 595-604
DOI: 10.1002/ohn.566 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 23.10.2023. Verfasst von Somya Shankar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Down Syndrome, Myocardial Infarction, Sleep Apnea, Obstructive. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
To better understand the long‐term health implications of obstructive sleep apnea (OSA) on patients with Trisomy 21 (T21) and the role of sleep surgery as a therapeutic intervention. Study Design Retrospective large database review.
Setting
The prevalence of OSA is as high as 75% in patients with T21. We sought to examine the cardiovascular, neurological, and endocrinological outcomes of patients with T21 10 years after their diagnosis of OSA.
Methods
TriNetX, an electronic medical record database, was queried for health outcomes in patients with T21 after diagnosis of OSA. The group was further analyzed to identify those who underwent sleep surgery, including hypoglossal nerve stimulation, palatopharyngoplasty, or adenotonsillectomy.
Results
Ten years after diagnosis, patients with OSA and T21 had a significantly higher incidence of death, myocardial infarction, cerebral infarction, heart failure, cardiac arrhythmia, ischemic heart disease, atrial fibrillation, essential hypertension, pulmonary hypertension, diabetes mellitus, and Alzheimer's disease compared to patients with T21 alone. Patients with OSA and T21 who underwent sleep surgery had significantly reduced incidence of adverse health outcomes compared to patients using continuous positive airway pressure.
Conclusion
Our findings suggest that patients with T21 and OSA are at higher risk of poor health outcomes, which may require closer monitoring for earlier diagnosis and management of comorbid conditions. Sleep surgery is a suitable treatment modality for mitigating the risk of adverse outcomes in this population and should be considered in patients who are eligible surgical candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Somya Shankar, Annie E Moroco
Zitieren
APA
Shankar, S., Moroco, A. E., Elliott, Z. T., Boon, M., & Huntley, C. (2024). Long‐Term Outcomes in Patients With Trisomy 21 and Obstructive Sleep Apnea. Otolaryngology–Head and Neck Surgery, 170(2), 595-604. https://doi.org/10.1002/ohn.566
Vancouver
Shankar S, Moroco AE, Elliott ZT, Boon M, Huntley C. Long‐Term Outcomes in Patients With Trisomy 21 and Obstructive Sleep Apnea. Otolaryngology–Head and Neck Surgery. 2024;170(2):595-604. doi:10.1002/ohn.566
BibTeX
@article{Shankar2024,
author = {Shankar, Somya and Moroco, Annie E and Elliott, Zachary T and Boon, Maurits and Huntley, Colin},
title = {Long‐Term Outcomes in Patients With Trisomy 21 and Obstructive Sleep Apnea},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
volume = {170},
number = {2},
pages = {595--604},
doi = {10.1002/ohn.566}
}
EUVIMED